J P M O R G A N Asia Pacific Equity Research 23 July 2026 Chugai Pharmaceutical (4519) Overseas results: Roche, Galderma 2Q FY2026 Roche and Galderma (both covered by Richard Vosser) announced 2Q (April- June) FY2026 results at 14:00 JST on July 23. Conference calls will be held at 21:00 by Roche and at 20:00 by Galderma. Chugai Pharmaceutical is due to announce its 2Q FY2026 results at 16:00 on July 24, followed by a conference call at 17:00. Among Roche's products, Hemlibra and Actemra both beat our estim ...

July 23, 2026 07:22 AM GMT Chugai Pharmaceutical (4519) | Japan M Update Roche and Galderma 2Q26 Results: Slightly Positive for Chugai Key Takeaways On Jul 23, Roche (covered by Sarita Kapila) and Galderma (covered by Thibault Boutherin) reported 2Q26 results. Roche maintained its full-year guidance, while Galderma raised guidance. Others: Global Actemra sales declined 14% YoY in Apr-Jun, worsening from -4% in Jan-Mar. Enspryng has completed its US filing for TED and remains on track for a MOGAD filing in 2 ...